共 131 条
- [1] Nitzkorski JR(2012)Outcome and natural history of patients with stage IV colorectal cancer receiving chemotherapy without primary tumor resection Ann Surg Oncol 19 379-383
- [2] Farma JM(2015)Påhlman L of the EGOSLIM (Expert Group on OncoSurgery management of LIver Metastases) group. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus Cancer Treat Rev 41 729-741
- [3] Watson JC(2015)Time trend analysis of primary tumor resection for stage IV colorectal cancer: less surgery, improved survival JAMA Surg 150 245-251
- [4] Siripurapu V(2018)Japanese Society for Cancer of the colon and Rectum (JSCCR) guidelines 2016 for the Treatment of Colorectal Cancer Int J Clin Oncol 23 1-34
- [5] Zhu F(2013)Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics Bone Marrow Transplant 48 452-458
- [6] Matteotti RS(2016)Regional lymph nodes status and ratio of metastatic to examined lymph nodes correlate with survival in stage IV colorectal cancer Ann Surg Oncol 23 2287-2294
- [7] Sigurdson ER(2011)Systemic review of prognostic factors related to overall survival in patients with stage IV colorectal cancer and unresectable metastases World J Surg 35 684-692
- [8] Adam R(1999)Incidence of colorectal carcinoma in the U.S.: an update of trends by gender, race, age, subsite, and stage, 1975-1994 Cancer. 85 1670-1676
- [9] de Gramont A(2012)Trends in colorectal cancer incidence rates in New Zealand, 1981-2004 ANZ J Surg 82 258-264
- [10] Figueras J(2018)Primary tumor location and survival in the general population with metastatic colorectal cancer Clin Colorectal Cancer 17 e201-e206